IP Library Granted Patent US 11,085,024
Granted Patent B2
US 11,085,024 · App. 17/013,389 · Granted Aug 10, 2021

System and method for extraction and cryopreservation of bone marrow

Inventors: Erik John Woods (Carmel, IN); Brian H. Johnstone (Fishers, IN); Dongsheng Gu (Indianapolis, IN); Aubrey Marie Sherry (Carmel, IN); Kelsey Gwen Musall (Avon, IN); John R. Woods (Indianapolis, IN); James Hardin (Columbia, SC); Alan Hooks (Commerce City, CO)
Assignee: Ossium Health, Inc.
C12N5/0663A01N1/0221A61B17/1611A61B2017/00831
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,085,024
App. No.
17/013,389
Granted
Aug 10, 2021
Kind
B2
Abstract

Methods are provided for extracting bone marrow cells from bone obtained from deceased donors, for preparing the bone marrow for cryopreservation and for obtaining desired cells from cryopreserved and fresh bone marrow.

Claims (24)

1. A method for recovery of transplantable stem cells from cadaver bone or cadaver bone fragments, the method comprising:

(a) obtaining cadaver bone or cadaver bone fragments, optionally, processing the cadaver bone into cadaver bone fragments;

(b) combining the cadaver bone fragments with a grinding medium comprising a nuclease that cleaves both DNA and RNA and one or more of human serum albumin (HSA), heparin, an electrolyte medium, and a growth media, thereby obtaining grinding medium-treated cadaver bone fragments;

(c) processing the grinding medium-treated cadaver bone fragments to extract bone marrow cells; and

(d) collecting the extracted bone marrow cells, thereby recovering the transplantable stem cells.

2. The method of claim 1 , wherein the nuclease is present in the grinding medium at a concentration of about 3 U/mL.

3. The method of claim 1 , wherein the electrolyte medium comprises a sterile, nonpyrogenic, isotonic solution.

4. The method of claim 1 , wherein the electrolyte medium comprises a pH of about 7.4.

5. The method of claim 1 , wherein the grinding medium comprises two or more of HSA, heparin, the electrolyte medium, and the growth media.

6. The method of claim 5 , wherein the grinding medium comprises three or more of HSA, heparin, the electrolyte medium, and the growth media.

7. The method of claim 1 , wherein the growth media is Iscove's Modified Dulbecco's Media (IMDM).

8. The method of claim 1 , wherein the processing in step (c) comprises grinding the cadaver bone fragments to obtain ground cadaver bone.

9. The method of claim 8 , wherein the processing in step (c) further comprises a filtering step thereby producing a filtered product comprising extracted bone marrow cells.

10. The method of claim 9 , wherein the filtering comprises a No. 40 (425 μm) sieve and/or a No. 80 (177 μm) sieve.

11. The method of claim 10 , further comprising combining the filtered product with additional grinding medium having components of step (b), thereby obtaining a diluted bone marrow cell product.

12. The method of claim 11 , further comprising a step of further filtering the diluted bone marrow cell product with one or more filters comprising pore sizes ranging from about 200 μm to about 825 μm and/or selected from filters having pore sizes of 200 μm, 500 μm, or 825 μm.

13. The method of claim of claim 12 , further comprising a step removing fat from an intermediate product.

14. The method of claim 1 , wherein the cadaver bone fragments are present in or divided into 1.5 cm 2 pieces in step (a).

15. The method of claim 1 , wherein the cadaver bone or the cadaver bone fragments are derived from a vertebral body, an ileum, or a combination thereof.

16. The method of claim 15 , wherein the cadaver bone or cadaver bone fragments are derived from a plurality of cadaver bones from the same donor.

17. The method of claim 1 , wherein the extracted stem cells comprise hematopoietic stem cells.

18. The method of claim 1 , wherein the extracted stem cells comprise a Mesenchymal stem cells (MSCs).

19. The method of claim 6 , wherein the grinding medium comprises the electrolyte medium, 10 U/mL heparin, 2.5% HSA, and 3 U/mL of the nuclease.

20. The method of claim 1 , wherein the transplantable stem cells are suitable for transplantation into a human subject.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 17, 2023
From: OSSIUM HEALTH, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065257/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2020
From: WOODS, ERIK J.; JOHNSTONE, BRIAN H.; GU, DONGSHENG; SHERRY, AUBREY M.; MUSALL, KELSEY G.; WOODS, JOHN R.; HARDIN, JAMES; HOOKS, ALAN
To: OSSIUM HEALTH, INC.
Reel/Frame 053748/0068 →
Continuity (4)
Continuation 16734713 · Jan 6, 2020
Provisional Application 62938480 · Nov 21, 2019
Provisional Application 62834087 · Apr 15, 2019
Related Publication 20200399605A1 · Dec 24, 2020
Cited By (3)
US 12,268,207 US 12,680,079 US 12,698,478